Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial |
| |
| Authors: | Dormandy John A,Charbonnel Bernard,Eckland David J A,Erdmann Erland,Massi-Benedetti Massimo,Moules Ian K,Skene Allan M,Tan Meng H,Lefèbvre Pierre J,Murray Gordon D,Standl Eberhard,Wilcox Robert G,Wilhelmsen Lars,Betteridge John,Birkeland Kåre,Golay Alain,Heine Robert J,Korányi László,Laakso Markku,Mokán Marián,Norkus Antanas,Pirags Valdis,Podar Toomas,Scheen André,Scherbaum Werner,Schernthaner Guntram,Schmitz Ole,Skrha Jan,Smith Ulf,Taton Jan PROactive investigators |
| |
| Affiliation: | Department of Clinical Vascular Research, Ingelby House, St Georges Hospital, Blackshaw Road, London SW17 0QT, UK. john.dormandy@btinternet.com |
| |
| Abstract: | ![]()
|
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
